These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Which strategy in inhibition of the renin-angiotensin system is the most efficient for heart failure? Ogihara T; Rakugi H J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):184-5. PubMed ID: 18957391 [No Abstract] [Full Text] [Related]
26. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure. Dzau VJ Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893 [TBL] [Abstract][Full Text] [Related]
27. Blockade of the renin-angiotensin system. Effect on mortality in patients with left ventricular systolic dysfunction. Pitt B Cardiol Clin; 1994 Feb; 12(1):101-14. PubMed ID: 8181019 [TBL] [Abstract][Full Text] [Related]
28. Lisinopril for hypertension. Med Lett Drugs Ther; 1988 Apr; 30(763):41-2. PubMed ID: 2832713 [No Abstract] [Full Text] [Related]
29. Angiotensin-converting enzyme inhibitors: are they all alike? Case DB J Clin Hypertens; 1987 Sep; 3(3):243-56. PubMed ID: 2822859 [TBL] [Abstract][Full Text] [Related]
30. [Current role of angiotensin II antagonists in the treatment of heart failure]. Porcu M; Orrù P Ital Heart J Suppl; 2000 Sep; 1(9):1213-4. PubMed ID: 11140296 [No Abstract] [Full Text] [Related]
31. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527 [No Abstract] [Full Text] [Related]
32. [The value of lysinopril in cardiac insufficiency]. Lambert M; Luccioni R Rev Prat; 1990 Oct; 40(23 Suppl):53-8. PubMed ID: 2176346 [TBL] [Abstract][Full Text] [Related]
35. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure. Lee CL; MacDonald GJ; Walsh WF Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831 [No Abstract] [Full Text] [Related]
36. CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure. McMurray JJ Eur J Heart Fail; 2011 Sep; 13(9):929-36. PubMed ID: 21816763 [TBL] [Abstract][Full Text] [Related]